{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:31:59Z","timestamp":1784302319231,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T00:00:00Z","timestamp":1697241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T00:00:00Z","timestamp":1697241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The clinical value of <jats:sup>18<\/jats:sup>F-fluorodeoxyglucose (FDG) positron emission tomography\/computed tomography (PET\/CT) in assessing relapsing polychondritis (RP) with airway involvement remains controversial. This study aimed to investigate PET\/CT features of RP with airway involvement and explore its clinical value in predicting disease pattern, severity and prognosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>RP patients with airway involvement who underwent PET\/CT from January 2010 to July 2022 were retrospectively reviewed. PET\/CT features were analyzed both visually and semiquantitatively with the maximum standardized uptake value (SUVmax) and total lesion glycolysis (TLG). Patterns of airway involvement on PET were summarized. Correlations of SUVmax and TLG of the airway were made with spirometric indicators and serological inflammatory markers (CRP and ESR). In addition, long-term follow-up was conducted through questionnaires in regard to symptom control, subjective feeling, pulmonary function, and quality of life.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Fifty-two cases were finally included. <jats:sup>18<\/jats:sup>F-FDG PET showed FDG-avid lesions with increased FDG uptake in the airway among 94.2% of the patients. Three patterns (focal, multifocal and diffuse patterns) were identified. TLG of the whole airway was lower in patients with previous therapy (<jats:italic>p<\/jats:italic>\u2009=\u20090.046). Bronchoscopy was more sensitive in detecting tracheal abnormalities (90.7% vs.53.5%, <jats:italic>p<\/jats:italic>\u2009=\u20090.039) but less sensitive for peripheral airway lesions (65.1% vs. 79.1%, <jats:italic>p<\/jats:italic>\u2009=\u20090.046) compared with PET. SUVmax and TLG of the airway positively correlated with spirometry indicators (FEV1%pred, FEV1\/FVC, MEF 50%pred, etc.) and serological inflammatory markers. Five patients died during the follow-up, with two deaths related to airway problems. Higher FDG uptake predicted worse subjective feeling, but not with symptom control or pulmonary function.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>PET\/CT is a valuable tool for RP with airway involvement, particularly in assessing peripheral airway lesions, and PET\/CT related parameters are significantly associated with disease patterns, severity, and long-term outcomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-023-03156-x","type":"journal-article","created":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T06:01:38Z","timestamp":1697263298000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Imaging features and clinical value of 18F-FDG PET\/CT for predicting airway involvement in patients with relapsing polychondritis"],"prefix":"10.1186","volume":"25","author":[{"given":"Jing-Wei","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Kai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Sheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,14]]},"reference":[{"key":"3156_CR1","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1093\/rheumatology\/kev240","volume":"54","author":"N Hazra","year":"2015","unstructured":"Hazra N, Dregan A, Charlton J, et al. Incidence and mortality of relapsing polychondritis in the UK: a population-based cohort study. Rheumatology (Oxford). 2015;54:2181\u20137. https:\/\/doi.org\/10.1093\/rheumatology\/kev240.","journal-title":"Rheumatology (Oxford)"},{"key":"3156_CR2","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1093\/rheumatology\/kex406","volume":"57","author":"J Kingdon","year":"2018","unstructured":"Kingdon J, Roscamp J, Sangle S, et al. Relapsing polychondritis: a clinical review for rheumatologists. Rheumatology (Oxford). 2018;57:1525\u201332. https:\/\/doi.org\/10.1093\/rheumatology\/kex406.","journal-title":"Rheumatology (Oxford)"},{"key":"3156_CR3","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1378\/chest.08-1180","volume":"135","author":"A Ernst","year":"2009","unstructured":"Ernst A, Rafeq S, Boiselle P, et al. Relapsing polychondritis and airway involvement. Chest. 2009;135:1024\u201330. https:\/\/doi.org\/10.1378\/chest.08-1180.","journal-title":"Chest"},{"key":"3156_CR4","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1002\/art.39790","volume":"68","author":"J Dion","year":"2016","unstructured":"Dion J, Costedoat-Chalumeau N, Sene D, et al. Relapsing polychondritis can be characterized by three different clinical phenotypes: analysis of a recent series of 142 Patients. Arthritis Rheumatol. 2016;68:2992\u20133001. https:\/\/doi.org\/10.1002\/art.39790.","journal-title":"Arthritis Rheumatol."},{"key":"3156_CR5","doi-asserted-by":"publisher","unstructured":"Zhang L, Wu TG, He YJ, et al. Diagnosing relapsing polychondritis remains a common challenge: experience from a Chinese retrospective cohort. Clin Rheumatol. 2020. https:\/\/doi.org\/10.1002\/art.39790.","DOI":"10.1002\/art.39790"},{"key":"3156_CR6","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s13075-019-2083-8","volume":"21","author":"Y Zeng","year":"2019","unstructured":"Zeng Y, Li M, Chen S, et al. Is (18)F-FDG PET\/CT useful for diagnosing relapsing polychondritis with airway involvement and monitoring response to steroid-based therapy? Arthritis Res Ther. 2019;21:282. https:\/\/doi.org\/10.1186\/s13075-019-2083-8.","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"3156_CR7","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/art.41270","volume":"72","author":"M Ferrada","year":"2020","unstructured":"Ferrada M, Rimland CA, Quinn K, et al. Defining clinical subgroups in relapsing polychondritis: a prospective observational cohort study. Arthritis Rheumatol. 2020;72(8):1396\u2013402. https:\/\/doi.org\/10.1002\/art.41270.","journal-title":"Arthritis Rheumatol"},{"key":"3156_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.7326\/0003-4819-104-1-74","volume":"104","author":"CJ Michet Jr","year":"1986","unstructured":"Michet CJ Jr, McKenna CH, Luthra HS, et al. Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med. 1986;104:74\u20138.","journal-title":"Ann Intern Med"},{"key":"3156_CR9","doi-asserted-by":"publisher","first-page":"102353","DOI":"10.1016\/j.autrev.2019.102353","volume":"18","author":"N de Montmollin","year":"2019","unstructured":"de Montmollin N, Dusser D, Lorut C, et al. Tracheobronchial involvement of relapsing polychondritis. Autoimmun Rev. 2019;18:102353. https:\/\/doi.org\/10.1016\/j.autrev.2019.102353.","journal-title":"Autoimmun Rev"},{"key":"3156_CR10","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1097\/rlu.0b013e31823eae56","volume":"37","author":"H Deng","year":"2012","unstructured":"Deng H, Chen P, Wang L, et al. Relapsing polychondritis on PET\/CT. Clin Nucl Med. 2012;37:712\u20135. https:\/\/doi.org\/10.1097\/rlu.0b013e31823eae56.","journal-title":"Clin Nucl Med"},{"key":"3156_CR11","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s12149-014-0805-1","volume":"28","author":"J Wang","year":"2014","unstructured":"Wang J, Li S, Zeng Y, et al. (1)(8)F-FDG PET\/CT is a valuable tool for relapsing polychondritis diagnose and therapeutic response monitoring. Ann Nucl Med. 2014;28:276\u201384. https:\/\/doi.org\/10.1007\/s12149-014-0805-1.","journal-title":"Ann Nucl Med"},{"key":"3156_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/s0140-6736(14)61946-2","volume":"385","author":"S Suzuki","year":"2015","unstructured":"Suzuki S, Ikegami A, Hirota Y, et al. Fever and cough without pulmonary abnormalities on CT: relapsing polychondritis restricted to the airways. Lancet. 2015;385:88. https:\/\/doi.org\/10.1016\/s0140-6736(14)61946-2.","journal-title":"Lancet"},{"key":"3156_CR13","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1056\/NEJMc072254","volume":"358","author":"F De Geeter","year":"2008","unstructured":"De Geeter F, Vandecasteele SJ. Fluorodeoxyglucose PET in relapsing polychondritis. N Engl J Med. 2008;358:536\u20137. https:\/\/doi.org\/10.1056\/NEJMc072254.","journal-title":"N Engl J Med"},{"key":"3156_CR14","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/rheumatology\/keu147","volume":"53","author":"H Yamashita","year":"2014","unstructured":"Yamashita H, Takahashi H, Kubota K, et al. Utility of fluorodeoxyglucose positron emission tomography\/computed tomography for early diagnosis and evaluation of disease activity of relapsing polychondritis: a case series and literature review. Rheumatology (Oxford). 2014;53:1482\u201390. https:\/\/doi.org\/10.1093\/rheumatology\/keu147.","journal-title":"Rheumatology (Oxford)"},{"key":"3156_CR15","doi-asserted-by":"publisher","first-page":"20150695","DOI":"10.1259\/bjr.20150695","volume":"89","author":"W Lei","year":"2016","unstructured":"Lei W, Zeng H, Zeng DX, et al. (18)F-FDG PET-CT: a powerful tool for the diagnosis and treatment of relapsing polychondritis. Br J Radiol. 2016;89:20150695. https:\/\/doi.org\/10.1259\/bjr.20150695.","journal-title":"Br J Radiol"},{"key":"3156_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/rheumatology\/kez243","volume":"59","author":"A Sharma","year":"2020","unstructured":"Sharma A, Kumar R, Mb A, et al. Fluorodeoxyglucose positron emission tomography\/computed tomography in the diagnosis, assessment of disease activity and therapeutic response in relapsing polychondritis. Rheumatology (Oxford). 2020;59:99\u2013106. https:\/\/doi.org\/10.1093\/rheumatology\/kez243.","journal-title":"Rheumatology (Oxford)"},{"key":"3156_CR17","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/01.rct.0000243459.46178.7d","volume":"31","author":"Y Nishiyama","year":"2007","unstructured":"Nishiyama Y, Yamamoto Y, Dobashi H, et al. [18F]fluorodeoxyglucose positron emission tomography imaging in a case of relapsing polychondritis. J Comput Assist Tomogr. 2007;31:381\u20133. https:\/\/doi.org\/10.1097\/01.rct.0000243459.46178.7d.","journal-title":"J Comput Assist Tomogr"},{"key":"3156_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/00005792-197605000-00001","volume":"55","author":"LP McAdam","year":"1976","unstructured":"McAdam LP, O\u2019Hanlan MA, Bluestone R, et al. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore). 1976;55:193\u2013215.","journal-title":"Medicine (Baltimore)"},{"key":"3156_CR19","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1288\/00005537-197906000-00009","volume":"89","author":"JM Damiani","year":"1979","unstructured":"Damiani JM, Levine HL. Relapsing polychondritis\u2013report of ten cases. Laryngoscope. 1979;89:929\u201346.","journal-title":"Laryngoscope"},{"key":"3156_CR20","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1183\/09031936.05.00035205","volume":"26","author":"R Pellegrino","year":"2005","unstructured":"Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948\u201368. https:\/\/doi.org\/10.1183\/09031936.05.00035205.","journal-title":"Eur Respir J"},{"key":"3156_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1081\/COPD-120030163","volume":"1","author":"Global Strategy for the Diagnosis","year":"2004","unstructured":"Global Strategy for the Diagnosis. Management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary updated 2003. COPD. 2004;1:105\u201341. https:\/\/doi.org\/10.1081\/COPD-120030163.","journal-title":"COPD"},{"key":"3156_CR22","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00256-015-2270-x","volume":"45","author":"WM Thaiss","year":"2015","unstructured":"Thaiss WM, Nikolaou K, Spengler W, et al. Imaging diagnosis in relapsing polychondritis and correlation with clinical and serological data. Skeletal Radiol. 2015;45:339\u201346. https:\/\/doi.org\/10.1007\/s00256-015-2270-x.","journal-title":"Skeletal Radiol"},{"key":"3156_CR23","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.3978\/j.issn.2072-1439.2014.08.21","volume":"6","author":"W Lei","year":"2014","unstructured":"Lei W, Zeng DX, Chen T, et al. FDG PET-CT combined with TBNA for the diagnosis of atypical relapsing polychondritis: report of 2 cases and a literature review. J Thorac Dis. 2014;6:1285\u201392. https:\/\/doi.org\/10.3978\/j.issn.2072-1439.2014.08.21.","journal-title":"J Thorac Dis"},{"key":"3156_CR24","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/RHU.0b013e31828635a9","volume":"19","author":"K Honne","year":"2013","unstructured":"Honne K, Nagashima T, Onishi S, et al. Fluorodeoxyglucose positron emission tomography\/computed tomography for diagnostic imaging in relapsing polychondritis with atypical manifestations. J Clin Rheumatol. 2013;19:104\u20135. https:\/\/doi.org\/10.1097\/RHU.0b013e31828635a9.","journal-title":"J Clin Rheumatol"},{"key":"3156_CR25","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2214\/ajr.178.1.1780173","volume":"178","author":"JV Behar","year":"2002","unstructured":"Behar JV, Choi YW, Hartman TA, et al. Relapsing polychondritis affecting the lower respiratory tract. AJR Am J Roentgenol. 2002;178:173\u20137. https:\/\/doi.org\/10.2214\/ajr.178.1.1780173.","journal-title":"AJR Am J Roentgenol"},{"key":"3156_CR26","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3109\/02841851003682036","volume":"51","author":"ZQ Lin","year":"2010","unstructured":"Lin ZQ, Xu JR, Chen JJ, et al. Pulmonary CT findings in relapsing polychondritis. Acta Radiol. 2010;51:522\u20136. https:\/\/doi.org\/10.3109\/02841851003682036.","journal-title":"Acta Radiol"},{"key":"3156_CR27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1017\/s0022215100144780","volume":"113","author":"COC Reina","year":"1999","unstructured":"Reina COC, Iriarte MTG, Reyes FJB, et al. When is a biopsy justified in a case of relapsing polychondritis? J Laryngol Otol. 1999;113:663\u20135. https:\/\/doi.org\/10.1017\/s0022215100144780.","journal-title":"J Laryngol Otol"},{"key":"3156_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-021-02482-2","volume":"23","author":"L Wan","year":"2021","unstructured":"Wan L, Gao Y, Gu J, et al. Total metabolic lesion volume of lymph nodes measured by 18F-FDG PET\/CT: a new predictor of macrophage activation syndrome in adult-onset Still\u2019s disease. Arthritis Res Ther. 2021;23:1\u20139. https:\/\/doi.org\/10.1186\/s13075-021-02482-2.","journal-title":"Arthritis Res Ther"},{"key":"3156_CR29","doi-asserted-by":"publisher","unstructured":"Bhattarai A, Nakajima T, Sapkota S, et al. Diagnostic value of 18F-fluorodeoxyglucose uptake parameters to differentiate rheumatoid arthritis from other types of arthritis. 2017;96:e7130. https:\/\/doi.org\/10.1097\/md.0000000000007130.","DOI":"10.1097\/md.0000000000007130"},{"key":"3156_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13550-020-00743-w","volume":"10","author":"K Mitamura","year":"2020","unstructured":"Mitamura K, Arai-Okuda H, Yamamoto Y, et al. Disease activity and response to therapy monitored by [18F]FDG PET\/CT using volume-based indices in IgG4-related disease. EJNMMI Res. 2020;10:1\u20136. https:\/\/doi.org\/10.1186\/s13550-020-00743-w.","journal-title":"EJNMMI Res"},{"key":"3156_CR31","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s00259-015-3148-9","volume":"43","author":"L Dellavedova","year":"2016","unstructured":"Dellavedova L, Carletto M, Faggioli P, et al. The prognostic value of baseline 18F-FDG PET\/CT in steroid-na\u00efve large-vessel vasculitis: introduction of volume-based parameters. Eur J Nucl Med Mol Imaging. 2016;43:340\u20138. https:\/\/doi.org\/10.1007\/s00259-015-3148-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3156_CR32","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s10067-013-2279-2","volume":"32","author":"G Hong","year":"2013","unstructured":"Hong G, Kim H. Clinical characteristics and treatment outcomes of patients with relapsing polychondritis with airway involvement. Clin Rheumatol. 2013;32:1329\u201335. https:\/\/doi.org\/10.1007\/s10067-013-2279-2.","journal-title":"Clin Rheumatol"},{"key":"3156_CR33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1017\/s002221512200038x","volume":"137","author":"SY Zhai","year":"2023","unstructured":"Zhai SY, Guo RY, Zhang C, et al. Clinical analysis of relapsing polychondritis with airway involvement. J Laryngol Otol. 2023;137:96\u2013100. https:\/\/doi.org\/10.1017\/s002221512200038x.","journal-title":"J Laryngol Otol"},{"key":"3156_CR34","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s12149-010-0406-6","volume":"24","author":"M Sato","year":"2010","unstructured":"Sato M, Hiyama T, Abe T, et al. F-18 FDG PET\/CT in relapsing polychondritis. Ann Nucl Med. 2010;24:687\u201390. https:\/\/doi.org\/10.1007\/s12149-010-0406-6.","journal-title":"Ann Nucl Med"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-023-03156-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-023-03156-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-023-03156-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:42:47Z","timestamp":1700268167000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-023-03156-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,14]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3156"],"URL":"https:\/\/doi.org\/10.1186\/s13075-023-03156-x","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,14]]},"assertion":[{"value":"22 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study gained the approval of our institutional review board(2020-k-17) and the informed consent was waived for this retrospective study analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"198"}}